Uptake of 5-hydroxytryptamine by isolated platelets in childhood schizophrenia and autism

Neuropsychobiology
|January 1, 1977
PubMed

Insights

Childhood schizophrenia and infantile autism show platelet abnormalities affecting serotonin accumulation. This defect is linked to the platelets themselves, not the plasma.

Area of Science:

  • Neuroscience
  • Biochemistry
  • Pediatrics

Background:

  • Previous research suggested platelet abnormalities in serotonin accumulation in childhood schizophrenia and infantile autism.
  • These findings pointed towards a potential role for platelets in these neurodevelopmental disorders.

Purpose of the Study:

  • To further validate and investigate the platelet abnormality in serotonin accumulation in infantile autism.
  • To determine if the observed defect resides within the platelets or the plasma.

Main Methods:

  • The study involved analyzing serotonin accumulation in platelets from individuals with infantile autism.
  • Comparative analysis was performed to differentiate between platelet-associated and plasma-associated defects.

Main Results:

  • The study confirmed a platelet abnormality in serotonin accumulation in infantile autism.
  • Evidence indicates the defect is intrinsic to the platelets, not attributable to plasma factors.

Conclusions:

  • The findings strengthen the association between platelet dysfunction and infantile autism.
  • The serotonin transport defect in infantile autism is localized to the platelet itself.

Related Concept Videos

Drugs Affecting Neurotransmitter Release or Uptake01:21

Drugs Affecting Neurotransmitter Release or Uptake

Certain drugs can affect how neurotransmitters called catecholamines, are released or taken back up in the adrenergic neuron. They can have different effects on the body's sympathetic transmission. Reserpine, a natural compound found in the Rauwolfia shrub, blocks a transporter called vesicular monoamine transporter (VMAT), which leads to a buildup of catecholamines in the cell and reduces sympathetic transmission. Another drug called guanethidine works in multiple ways, including blocking...
Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders01:27

Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders

Schizophrenia is a neurodevelopmental disorder whose origins are rooted in complex genetic components. Despite our burgeoning understanding, the pathophysiology of this disorder remains incompletely deciphered.
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within the...
Biological Causes of Schizophrenia01:29

Biological Causes of Schizophrenia

Schizophrenia, a severe psychiatric disorder, arises from a complex interplay of biological factors, including genetic predisposition, structural brain abnormalities, neurotransmitter dysregulation, and developmental irregularities. These factors collectively contribute to the onset and progression of the disorder, which typically manifests in late adolescence or early adulthood.
Genetic Factors in Schizophrenia
The genetic basis of schizophrenia is strongly supported by family and twin studies.
Psychological and Sociocultural Causes of Schizophrenia01:29

Psychological and Sociocultural Causes of Schizophrenia

Schizophrenia, a complex psychiatric disorder, has been historically misunderstood. Early psychological theories attributed its origins to childhood trauma and unresponsive parenting. However, contemporary research largely rejects these notions, favoring the vulnerability-stress hypothesis. This model proposes that individuals with a genetic predisposition to schizophrenia may develop the disorder following exposure to significant environmental stressors. Notably, studies on high-risk...